You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Chlordiazepoxide And Amitriptyline Hydrochloride patents expire, and when can generic versions of Chlordiazepoxide And Amitriptyline Hydrochloride launch?

Chlordiazepoxide And Amitriptyline Hydrochloride is a drug marketed by Anda Repository, Chartwell Rx, Heritage Pharma, Micro Labs, Mylan Pharms Inc, and Usl Pharma. and is included in ten NDAs.

The generic ingredient in CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride; chlordiazepoxide. There are thirteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amitriptyline hydrochloride; chlordiazepoxide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE?
  • What are the global sales for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE?
  • What is Average Wholesale Price for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE?
Summary for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE
Drug patent expirations by year for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE
Recent Clinical Trials for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE clinical trials

Pharmacology for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE

US Patents and Regulatory Information for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anda Repository CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 070765-001 Dec 10, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 211925-001 Feb 2, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 072278-001 May 9, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Usl Pharma CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 070478-001 Jan 12, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 211925-002 Feb 2, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Anda Repository CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 070766-001 Dec 10, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 072277-001 May 9, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.